Latest Transformation News

AGL Energy reported a steady half-year performance with flat EBITDA and a slight dip in net profit, underpinned by improved operational metrics and strategic moves including a major telco divestment and renewable investments.

Pantera Minerals has completed its inaugural modern geochemical sampling program at the Gilham Silver-Antimony Project in Arkansas, uncovering new geological insights and setting the stage for drilling. The company maintains a disciplined capital approach amid rising silver prices.

AGL Energy reported a steady first half with flat underlying EBITDA and a narrowed FY26 earnings outlook, while accelerating its renewable projects and forming a strategic partnership with Aussie Broadband.

Podium Minerals has appointed mining heavyweight Neal Froneman as Non-Executive Chairman, alongside key executive promotions, setting the stage for accelerated development of its Parks Reef PGM Project in Western Australia.

Noxopharm Limited has secured a major scientific milestone with the publication of its Sofra™ platform research in Nature Immunology, highlighting a novel anti-inflammatory mechanism with broad therapeutic potential.

CSL Limited has released its half-year results showing a slight revenue decline amid ongoing transformation efforts, while maintaining its full-year guidance and expanding its share buyback program.

CSL Limited reported a 7% decline in underlying NPATA to US$1.9 billion for the half-year, weighed down by restructuring costs and impairments, yet maintains full-year guidance and expands its share buy-back program.

CSL Limited reported a sharp 80% drop in net profit for the half year ended December 2025, driven by significant restructuring and impairment charges, yet maintained its growth guidance and dividend payout.

SGH Ltd reported a solid half-year profit of $472.6 million, declaring a fully franked 32 cent dividend, while completing a major media merger that reshapes its investment portfolio.

Commonwealth Bank of Australia reported a robust half-year result for December 2025, with a 6% rise in cash NPAT to $5.445 billion and a 10-cent dividend increase, underpinned by disciplined growth and strong capital management.

ASX Limited announces that CEO Helen Lofthouse will step down in May 2026, coinciding with the imminent go-live of the CHESS project’s first phase. The Board initiates a global search for new leadership to guide the next stage of transformation.

CSL Limited announces the retirement of CEO Dr Paul McKenzie, with veteran executive Gordon Naylor appointed as interim CEO and Managing Director. The leadership change marks a new chapter for the biotech giant amid ongoing strategic transformation.